PAGDF yields 5.91% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, PAGDF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PAGDF + PFE for your $10,000?
Paragon ID SA provides identification solutions worldwide. It offers access control, brand protection, contactless ticketing, label, customer relationship management, magnetic and mobile ticketing, near field communication, operation maintenance, RFID technology, secure application module, smartcard kiosk, stock management, timed use ticketing, transport item tracking, and secure service solutions. The company also provides contactless and dual interface smart cards, identification documents, metal bank cards, passport E-covers, RFID labels, and eTrust that transforms secure paper-based products into intelligent documents, as well as various terminals, including couplers, readers, and accessories. It serves various clients in automotive, aviation, gaming, health, higher education, logistics, luxury products, manufacturing, mass transit and transport, mobility, parking, payment, pharmaceutical, retail, secure ID, and sport and leisure industries. The company was incorporated in 2019 and is headquartered in Mougins, France. Paragon ID SA is a subsidiary of Paragon Group Limited.
Full PAGDF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.